SCN1A and Dravet syndrome: The first preclinical confirmations for antiseizure effects of racemic fenfluramine in models of Dravet syndrome came from pharmacological analysis in an antisense knockdown zebrafish model and an scn1a mutant zebrafish model.131, 132